Creative Planning - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 41 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Creative Planning ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$24,000
-11.1%
7,611
-4.9%
0.00%
Q1 2017$27,000
+68.8%
8,000
+48.1%
0.00%
Q4 2016$16,000
-44.8%
5,400
+8.0%
0.00%
Q3 2016$29,000
+93.3%
5,0000.0%0.00%
Q2 2016$15,000
-44.4%
5,0000.0%0.00%
Q1 2016$27,000
-54.2%
5,0000.0%0.00%
Q4 2015$59,000
+1080.0%
5,000
+2400.0%
0.00%
Q2 2014$5,0002000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$89,888,00013.40%
EcoR1 Capital, LLC 3,627,597$79,916,0007.20%
Aquilo Capital Management, LLC 614,436$13,536,0005.08%
RTW INVESTMENTS, LP 5,874,229$129,409,0004.88%
BRIDGER MANAGEMENT, LLC 1,981,633$43,655,0003.15%
ACUTA CAPITAL PARTNERS, LLC 387,500$8,537,0002.11%
Integral Health Asset Management, LLC 200,000$4,406,0001.72%
Burrage Capital Management LLC 104,047$2,292,0001.54%
Parkman Healthcare Partners LLC 240,000$5,287,0001.53%
EAM Global Investors LLC 122,237$2,693,0001.08%
View complete list of DICERNA PHARMACEUTICALS INC shareholders